Alteration of cytokeratin expression in oral lichen planus.
The purpose of this investigation is to examine the possible biochemical and topographic cytokeratin alterations in lichen planus of oral mucosa. Biopsy samples of clinically normal buccal mucosa (n = 5), normal gingiva (n = 5), lichen planus from buccal mucosa (n = 5), and lichen planus from gingiva (n = 5) were obtained from patients of both sexes. Cytokeratin expression was determined by means of immunohistochemical labeling with use of a battery of monoclonal antibodies against cytokeratins and filaggrin and two-dimensional gel electrophoresis. In buccal mucosa, which is not keratinized cytokeratins 4 and 13 are expressed in the majority. In buccal mucosa lichen planus, the appearance of cytokeratins 1, 2, 10, and 11 coincides with a decrease in cytokeratins 4 and 13 and a moderate increase in cytokeratins 6, 16, 17, and 19. In normal gingiva, which is normally keratinized, the main cytokeratins are 1, 2, 10, and 11. In gingival lichen planus, a slight decrease in these cytokeratins and in cytokeratin 13 expression was noted. Finally, alterations in cytokeratins 5 and 14, explained by marked alterations of basal cells, were observed. The battery of antibodies used in this study, in correlation with two-dimensional gel electrophoresis, could represent useful diagnostic tools that enable the distinction between inflammatory keratosis and so-called quiescent lichen planus. Moreover, this work showed that cytokeratins 1, 2, 10, and 11 and filaggrin are sensitive tools that may help detect early relapse before clinical exacerbation. Finally, these biochemical techniques may be useful to follow the evolution of lichen planus under treatment.
Boisnic
S
S
Service Central d'Anatomie et Cytologie Pathologiques, Hôpital de la Pitié, Paris, France.
Ouhayoun
J P
JP
Branchet
M C
MC
Frances
C
C
Béranger
J Y
JY
Le Charpentier
Y
Y
Szpirglas
H
H
D000911:Antibodies, Monoclonal; D003937:Diagnosis, Differential; D018450:Disease Progression; D015180:Electrophoresis, Gel, Two-Dimensional; D005260:Female; D000091344:Filaggrin Proteins; D005455:Fluorescent Antibody Technique; D005881:Gingiva / Q000737:chemistry*; D006801:Humans; D007381:Intermediate Filament Proteins / Q000032:analysis; D007633:Keratins / Q000032:analysis*; D007972:Leukoplakia, Oral / Q000175:diagnosis / Q000378:metabolism*; D017676:Lichen Planus, Oral / Q000175:diagnosis / Q000378:metabolism*; D008297:Male; D009061:Mouth Mucosa / Q000737:chemistry*
D000911:Antibodies, Monoclonal; C000717249:FLG protein, human; D000091344:Filaggrin Proteins; D007381:Intermediate Filament Proteins; D007633:Keratins